VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $12,188,000 | -30.9% | 119,900 | +55.3% | 0.31% | -29.8% |
| Q3 2015 | $17,638,000 | +2.8% | 77,200 | 0.0% | 0.45% | -0.2% |
| Q2 2015 | $17,150,000 | -5.8% | 77,200 | -15.8% | 0.45% | +1.6% |
| Q1 2015 | $18,213,000 | +11.7% | 91,700 | -26.2% | 0.44% | +10.0% |
| Q4 2014 | $16,308,000 | +44.7% | 124,300 | +44.7% | 0.40% | +65.7% |
| Q3 2014 | $11,270,000 | +4.0% | 85,900 | 0.0% | 0.24% | +7.6% |
| Q2 2014 | $10,834,000 | +103.9% | 85,900 | +113.2% | 0.22% | +95.7% |
| Q1 2014 | $5,313,000 | – | 40,300 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |